3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Unknown
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other solid neoplasm
2
Conditions
Carcinoma, Non-Small-Cell Lung
18
Breast Neoplasms
15
Pancreatic Neoplasms
13
Colorectal Neoplasms
10
Rectal Neoplasms
7
Stomach Neoplasms
6
Neoplasm Metastasis
6
Lung Neoplasms
6
Neoplasms
5
Recurrence
4
Ovarian Neoplasms
4
Uterine Cervical Neoplasms
3
Small Cell Lung Carcinoma
3
Prostatic Neoplasms
3
Lymphoma, T-Cell, Peripheral
3
Leukemia, Myeloid, Acute
3
Esophageal Squamous Cell Carcinoma
3
Colonic Neoplasms
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Treatment
2
Solid Tumor
2
Small Cell Lung Cancer Limited Stage
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Lymphoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Esophageal Neoplasms
2
Interventions
Fluorodeoxyglucose F18
4
Drug Therapy
2
nimotuzumab
1
apatinib
1
Ultrasonography, Doppler
1
Ultrasonography
1
Sirolimus
1
Re-Irradiation
1
Radiosurgery
1
RE1-silencing transcription factor
1
Proton Therapy
1
Ink
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Solid Tumor
×
Drug Therapy
×
Clear all
NCT04214717
2023-03-28
DC-CIK
Yantai Yuhuangding Hospital
Phase NA
Unknown
60 enrolled
NCT04214730
2023-03-28
NK
Yantai Yuhuangding Hospital
Phase NA
Unknown
60 enrolled